Russia's Retina.AI revolutionizes eye care with cloud-based AI diagnostics

Doctors at several ophthalmology clinics and federal medical centers in Russia are now diagnosing patients using Retina.AI, the country's first cloud-based AI-powered decision support system for ophthalmology. Originally designed to analyze retinal scans in diabetic patients—who face a high risk of vision impairment and blindness—the platform can now detect a wider range of eye conditions.

International studies suggest that similar AI systems abroad have reduced diabetes-related blindness and severe vision loss by 11%. Russian physicians using Retina.AI report that the platform helps minimize errors in interpreting retinal images, enabling earlier detection of retinal pathologies. It also speeds up diagnoses—a critical advantage given Russia's shortage of ophthalmologists. However, some skeptics question the system's reliability, noting that its AI was trained on a relatively small dataset of retinal scans, raising concerns about potential misdiagnoses.

As in many other countries, Russian healthcare is increasingly adopting artificial intelligence to identify medical conditions. Over the past few years, radiologists have officially integrated AI tools to analyze X-rays and CT scans of the brain, lungs, heart, liver, kidneys, and other organs. Leading developers in this field include companies like K-Sky, Celsus, Visionero, Third Opinion, and Doctor Nearby. Until recently, though, no one in Russia had focused on AI solutions specifically for ophthalmology.

The first to take on the challenge was Digital Vision Solutions, an innovative IT company and a resident of the Skolkovo innovation hub. Since 2021, its team of just 11—doctors, software engineers, machine vision experts, and project managers—has been training an AI algorithm on retinal images, culminating in the Retina.AI application. Last year, the platform was launched for commercial use in clinics.